Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Do you know your PSMA-tracer? Variability in the biodistribution of different PSMA ligands and its potential impact on defining PSMA-positivity prior to PSMA-targeted therapy.
Heilinger J, Roth KS, Weis H, Fink A, Weindler J, Dietlein F, Krapf P, Schomäcker K, Neumaier B, Dietlein M, Drzezga A, Kobe C. Heilinger J, et al. Among authors: kobe c. EJNMMI Res. 2025 Jan 10;15(1):4. doi: 10.1186/s13550-024-01190-7. EJNMMI Res. 2025. PMID: 39792324 Free PMC article.
Correlation Between Progression-Free and Overall Survival in Patients with Hodgkin Lymphoma: A Comprehensive Analysis of Individual Patient Data from Randomized GHSG Trials.
Bröckelmann PJ, Müller H, Fuchs M, Gillessen S, Eichenauer DA, Borchmann S, Jacob AS, Behringer K, Momotow J, Ferdinandus J, Böll B, Yang X, Kobe C, Eich HT, Baues C, Klapper W, Engert A, Borchmann P, von Tresckow B. Bröckelmann PJ, et al. Among authors: kobe c. Ann Oncol. 2024 Dec 18:S0923-7534(24)04988-3. doi: 10.1016/j.annonc.2024.12.009. Online ahead of print. Ann Oncol. 2024. PMID: 39706337 Free article.
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology.
Wegen S, Nestle U, Zamboglou C, Spohn SKB, Nicolay NH, Unterrainer LM, Koerber SA, La Fougère C, Fokas E, Kobe C, Eze C, Grosu AL, Fendler WP, Holzgreve A, Werner R, Schmidt-Hegemann NS. Wegen S, et al. Among authors: kobe c. Strahlenther Onkol. 2024 Nov;200(11):931-941. doi: 10.1007/s00066-024-02260-4. Epub 2024 Aug 9. Strahlenther Onkol. 2024. PMID: 39120747 Free PMC article.
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.
Boellaard R, Buvat I, Nioche C, Ceriani L, Cottereau AS, Guerra L, Hicks RJ, Kanoun S, Kobe C, Loft A, Schöder H, Versari A, Voltin CA, Zwezerijnen GJC, Zijlstra JM, Mikhaeel NG, Gallamini A, El-Galaly TC, Hanoun C, Chauvie S, Ricci R, Zucca E, Meignan M, Barrington SF. Boellaard R, et al. Among authors: kobe c. J Nucl Med. 2024 Sep 3;65(9):1343-1348. doi: 10.2967/jnumed.124.267789. J Nucl Med. 2024. PMID: 39089812 Free PMC article.
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, Schaub V, Hüttmann A, Keil F, Dierlamm J, Hänel M, Novak U, Meissner J, Zimmermann A, Mathas S, Zijlstra JM, Fosså A, Viardot A, Hertenstein B, Martin S, Giri P, Scholl S, Topp MS, Jung W, Vucinic V, Beck HJ, Kerkhoff A, Unger B, Rank A, Schroers R, Zum Büschenfelde CM, de Wit M, Trautmann-Grill K, Kamper P, Molin D, Kreissl S, Kaul H, von Tresckow B, Borchmann S, Behringer K, Fuchs M, Rosenwald A, Klapper W, Eich HT, Baues C, Zomas A, Hallek M, Dietlein M, Kobe C, Diehl V; German Hodgkin Study Group; Swiss Group for Clinical Cancer Research; Arbeitsgemeinschaft Medikamentöse Tumortherapie; Nordic Lymphoma Group; Australasian Leukaemia and Lymphoma Group. Borchmann P, et al. Among authors: kobe c. Lancet. 2024 Jul 27;404(10450):341-352. doi: 10.1016/S0140-6736(24)01315-1. Epub 2024 Jul 3. Lancet. 2024. PMID: 38971175 Free article. Clinical Trial.
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group.
Rosenbrock J, Kaul H, Oertel M, Celik E, Linde P, Fan J, Eichenauer DA, Bröckelmann PJ, von Tresckow B, Kobe C, Dietlein M, Fuchs M, Borchmann P, Eich HT, Baues C. Rosenbrock J, et al. Among authors: kobe c. Int J Radiat Oncol Biol Phys. 2024 Dec 1;120(5):1344-1352. doi: 10.1016/j.ijrobp.2024.04.015. Epub 2024 Apr 15. Int J Radiat Oncol Biol Phys. 2024. PMID: 38631539 Free article. Clinical Trial.
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.
Schuler M, Hense J, Darwiche K, Michels S, Hautzel H, Kobe C, Lueong S, Metzenmacher M, Herold T, Zaun G, Laue K, Drzezga A, Theegarten D, Nensa F, Wolf J, Herrmann K, Wiesweg M. Schuler M, et al. Among authors: kobe c. J Nucl Med. 2024 Jun 3;65(6):851-855. doi: 10.2967/jnumed.123.266979. J Nucl Med. 2024. PMID: 38575188 Clinical Trial.
182 results